Manhattan Scientifics INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Manhattan Scientifics, Inc. reported a net loss of $540,000 for the six months ended June 30, 2024, an improvement compared to the $649,000 loss in the same period of 2023.
OTC.Pink
Manhattan Scientifics reported a net loss of $382,000 for the first quarter of 2024, an improvement compared to the $420,000 loss in the same period last year.